Hydrochlorothiazide
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-22-R-0115
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents5
This solicitation, identified by Procurement Identifier SPE2D2-22-R-0115, is issued by DLA Troop Support, a federal office responsible for providing critical supplies to military and federal entities. The notice pertains to the procurement of Hydrochlorothiazide, a pharmaceutical product, under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505, which covers drugs and biologicals. The current modification, MOD P00009, exercises Option Year Three (3) of the contract, indicating a continuation of an existing multi-year agreement.
The primary objective of this procurement is to ensure a reliable supply of Hydrochlorothiazide, a medication widely used for managing hypertension and edema, to meet the ongoing needs of federal agencies and military operations. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Hydrochlorothiazide in accordance with stringent federal quality and safety standards. Contractors are expected to maintain consistent production capabilities, adhere to regulatory requirements, and ensure timely delivery to designated locations as specified by DLA Troop Support.
Key requirements for this solicitation include demonstrated experience in pharmaceutical preparation manufacturing, compliance with all applicable federal regulations, and the ability to provide Hydrochlorothiazide in the required formulations and quantities. The expected deliverables center on the uninterrupted supply of the medication, with quality assurance and documentation as integral components of contract performance.
DLA Troop Support, as the contracting entity, is based within the federal government structure and serves as the primary point of contact for this procurement. Interested parties may direct inquiries to Ryan Ferry ([email protected], 215-737-3182) or Jason Wray ([email protected], 215-737-0614) for further information regarding the solicitation.
This opportunity is classified as a solicitation and remains active as of the posting date. Contractors should review the attached documents on the official SAM.gov listing (https://sam.gov/opp/223287bb1e7a4b058d72cdda8f5d695f/view) for comprehensive details and submission requirements. While specific set-aside requirements or special considerations are not detailed in the provided information, contractors should ensure alignment with the NAICS and PSC codes and be prepared to meet the long-term supply needs outlined by DLA Troop Support.
Overall, this procurement represents a significant opportunity for qualified pharmaceutical manufacturers to support federal healthcare and operational readiness through the supply of a critical medication. Contractors with established capabilities in pharmaceutical production and federal contracting experience are encouraged to evaluate this opportunity in detail.